In the percent study, we showed that PLK1 as a key downstream target of the HN1L/AP-2γ pathway promoted ESCC progression by up-regulation of cell cycle-related gene CCND1 and metastasis regulatory gene SLUG. These results are supported by other studies. This evidence concerns the gene SNAI2 and esophageal squamous cell carcinoma.